Understanding and improving the safety of medicines in old age

Date Published: 
6 November 2019
Target Sites: 
Medicine (select for all events)
Medicine Staff Website (select for events only)
Digital Signage (Select for all Randwick/Kensington based events)
image - Hilmer 15 11 19
Event date: 
15 November 2019 - 4:00pm
Wallace Wurth Building LG02 UNSW
Event Type: 
Event open to: 
Booking deadline: 

Neuroscience & Non-Communicable Diseases Seminar Series

Speaker: Professor Sarah Hilmer, Dept Clinical Pharmacology, USYD

Sarah Hilmer (BScMed (Hons 1) MBBS(Hons) FRACP PhD) is a senior staff specialist geriatrician and head of department of clinical pharmacology at Royal North Shore Hospital (RNSH) and Conjoint Professor of Geriatric Pharmacology at the University of Sydney. She leads a translational research program in Ageing and Pharmacology at the Kolling Institute in addition to her clinical, policy, teaching and administrative responsibilities.

Hilmer has broad translational expertise in geriatric pharmacology research assessing the association of medication use with geriatric syndromes including frailty, falls and cognitive impairment. Her basic pharmacology research includes studies of hepatic metabolism and drug hepatotoxicity in old age, effects of polypharmacy on frailty, effects of frailty on pharmacokinetics/pharmacodynamics, and effects of anti-ageing interventions on frailty. She developed the Drug Burden Index (DBI), a pharmacologic measure of exposure to high-risk medicines. She and others internationally have published pharmaco-epidemiologic evaluations of DBI, she has conducted RCTs of DBI as a clinical decision support tool, and implementation studies are underway in Australia and internationally.

All welcome. Drinks and snacks from 3:30pm, seminar starts, 4pm.

Natasha Kumar; Natasha.kumar@unsw.edu.au
Ingvars Birznieks; i.birznieks@unsw.edu.au

File Attachment: